Caryl and Israel Englander
Institute for Precision Medicine

You are here

what is precision medicine?

News

Latest news from The Englander Institute for Precision Medicine:

 

September 21, 2016

Researchers can now predict the odds of experimental drugs succeeding in clinical trials, thanks to a new data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may disqualify drugs from human use, giving drug developers an early warning before initiating clinical trials, according to a new study published Sept. 15 inCell Chemical Biology.


September 5, 2016
Alex Sigaras demonstrates the Oculus virtual reality system In the 1966 film Fantastic Voyage, physicians were shrunk down to microscopic size to travel inside the human body and save a dying patient. Now, researchers at Weill Cornell Medicine are using virtual reality goggles to bring that fantasy to life—with the aim of improving cancer care.
September 1, 2016
The launch of President Obama’s Precision Medicine Initiative is putting a cutting-edge approach to research and patient care on the map. Academic medical centers have been pioneering the development of precision medicine for more than a decade—and now it’s time for the biopharmaceutical industry to get deeper in the game.
August 3, 2016

In order to benefit from the latest advances in precision medicine, Himisha Beltran, M.D., has to subject her prostate cancer patients to invasive biopsies that can be painful, expensive, difficult to perform, and not always feasible.

But she is hoping to harness new genomic sequencing technologies to track tumor activity from a simple blood draw, and a $1 million grant from the Prostate Cancer Foundation may help make the dream a clinical reality.


July 21, 2016
A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy, according to new research. The scientists say their findings, published July 20 in NPJ Genomic Medicine, validate the test, called Weill Cornell Medicine EXaCT-1, and demonstrate its feasibility in a clinical setting.

Weill Cornell Medicine
Caryl and Israel Englander
Institute for Precision Medicine
413 E 69th Street
Belfer Research Building
New York, NY 10021 Phone: